Admelog

Active Ingredient(s): Insulin Lispro
FDA Approved: * December 11, 2017
Pharm Company: * SANOFI-AVENTIS US
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Admelog Overview

Insulin lispro, sold under the brand name Humalog among others, is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market.[2] Engineered through recombinant DNA technology, the penultimate lysine and proline residues on the C-terminal end of the B-chain are reversed. This modification does not alter receptor binding, but blocks the formation of insulin dimers and hexamers. This allows larger amounts of a...

Read more Admelog Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Insulin_lispro

Recent Admelog Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Insulin Lispro
  • Injection: 100 Units/ml, 100unit/ml, 200units/ml
  • Solution: 1000 Units/10ml (100 Units/ml), 200 Units/ml, 300 Units/3ml (100 Units/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Admelog: (2 results)

Sorted by National Drug Code
  • 0024-5924 Admelog 100 U/Ml Intravenous; Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5925 Admelog 100 U/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC

Other drugs which contain Insulin Lispro or a similar ingredient: (3 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 23 May 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.